Product Information
FUROSEMIDE 20 MG/2 ML VIAL is a generic product labeled by Avenacy Inc., priced at $0.4901 per ML under NDC 83634030202. Its NADAC has been published 99 times since Nov 13, 2024.
FDA first approved this application on Aug 26, 2014. Its Orange Book therapeutic-equivalence code is AP.
Strength
10 mg/mL
Manufacturer
Avenacy Inc.NDC
83634030202
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Effective Date
9/23/2026
Active Ingredients
FUROSEMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA203428FDA Approved
8/26/2014
TE Code
AP
On Market Since
3/15/2024
Pharmacological Classes
Price Statistics
The NADAC for FUROSEMIDE 20 MG/2 ML VIAL has been published 99 times since Nov 13, 2024, and over the history we have for it it has declined 6.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4901 per ML |
|---|---|
| All-time high | $0.5258 (Dec 11, 2024) |
| All-time low | $0.3473 (Dec 17, 2025) |
| 52-week high | $0.4901 |
| 52-week low | $0.3473 |
| Median price | $0.4073 |
| Average price | $0.4056 |
| Largest weekly change | -22.5% (Dec 18, 2024) |
| Weeks tracked | 99 |
| Tracking since | Nov 13, 2024 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 52% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Avenacy Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
furosemide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Loop Diuretic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FUROSEMIDE 20 MG/2 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for FUROSEMIDE 20 MG/2 ML VIAL, manufactured by Avenacy Inc., is $0.4901 per ML (NDC 83634030202), effective Sep 30, 2026.
How has the price of FUROSEMIDE 20 MG/2 ML VIAL changed over time?
Over the history we have for it, the NADAC for FUROSEMIDE 20 MG/2 ML VIAL has declined 6.8%. It has been tracked across 99 weekly CMS publications since Nov 13, 2024.
What are the highest and lowest recorded NADAC prices for FUROSEMIDE 20 MG/2 ML VIAL?
Since Nov 13, 2024, the NADAC for FUROSEMIDE 20 MG/2 ML VIAL has ranged from a low of $0.3473 (Dec 17, 2025) to a high of $0.5258 (Dec 11, 2024), with a median of $0.4073 per ML.
Are there cheaper alternatives to FUROSEMIDE 20 MG/2 ML VIAL?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FUROSEMIDE 40 MG/4 ML VIAL, is $0.2334 per ML — about 52% below FUROSEMIDE 20 MG/2 ML VIAL.
Who manufactures FUROSEMIDE 20 MG/2 ML VIAL?
FUROSEMIDE 20 MG/2 ML VIAL (NDC 83634030202) is labeled by Avenacy Inc., and CMS classifies it as a generic product.